These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6192580)

  • 1. [Importance of impulse cytophotometry in the diagnosis and prognosis of prostate cancer].
    Zimmermann A; Truss F; Blech M; Schröter W; Barth M
    Urologe A; 1983 May; 22(3):151-6. PubMed ID: 6192580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fine needle aspiration cytology (FNAC) in the diagnosis of prostatic lesions with histologic correlation.
    Saleh AF; Nahar Rahman AJ; Salam MA; Islam F
    Bangladesh Med Res Counc Bull; 2005 Dec; 31(3):95-103. PubMed ID: 17549870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical hyperplasia of the prostate. A pitfall in the cytologic diagnosis of carcinoma.
    de Gaetani CF; Trentini GP
    Acta Cytol; 1978; 22(6):483-6. PubMed ID: 83770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible use of DNA cytophotometry and karyometry for the cytological diagnosis of human prostate cancer].
    Selivanova GV; Vorob'ev AV
    Tsitologiia; 1983 Jul; 25(7):765-70. PubMed ID: 6194599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine needle aspiration of the prostate: a histo-cytological correlation.
    Raica M; Bajan F
    Rom J Morphol Embryol; 1991; 37(3-4):137-42. PubMed ID: 1726058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative cytologic and flow-through cytophotometric studies in prostate cells (author's transl)].
    Zimmermann A; Truss F
    Urologe A; 1978 Nov; 17(6):391-4. PubMed ID: 726165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic squamous cell cancer and its differential diagnostic contrast with squamous cell metaplasia].
    Samsonov VA
    Arkh Patol; 1984; 46(8):23-9. PubMed ID: 6208883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of flow cytometry and automated image analysis to the study of prostate cancer.
    Benson MC
    NCI Monogr; 1988; (7):25-9. PubMed ID: 3050538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
    Maksimov VA; Kamalov AA; Karpov VK; Riaboĭ AV; Prokhorov AV
    Urologiia; 2001; (2):37-40. PubMed ID: 11490716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thin-needle aspiration biopsy of the prostate.
    Koss LG; Woyke S; Schreiber K; Kohlberg W; Freed SZ
    Urol Clin North Am; 1984 May; 11(2):237-51. PubMed ID: 6203204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of 10 systematized and ultrasound-guided transrectal prostatic biopsies].
    Ravery V; Billebaud T; Toublanc M; Boccon-Gibod L; Hermieu JF; Moulinier F; Blanc E; Delmas V; Boccon-Gibod L
    Prog Urol; 1998 Dec; 8(6):1012-7. PubMed ID: 9894260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular forms of PSA and differentiating between benign hypertrophy,carcinoma, and disseminated prostatic carcinoma. Correlation between two determination technics].
    Sáez Lavilla C; Guallar Labrador A; Castrillo Rubio J; Allepuz Losa CA; Baringo Fuentes T; Ascaso Bandrés A; Navarro Izquierdo AL; Rioja Sanz LA
    Arch Esp Urol; 1999 May; 52(4):315-21. PubMed ID: 10380320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign mimics of prostatic adenocarcinoma on needle biopsy.
    Gaudin PB; Reuter VE
    Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flow cytometric determination of DNA distribution patterns of malignant and benign tumors of the prostate (author's transl)].
    Lämmel A; Roters M; Kastendieck H; Becker H
    Urologe A; 1981 Nov; 20(6):400-4. PubMed ID: 6171922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
    Yesner R; Kelly LJ; Chan YK
    Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
    Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
    Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia.
    Maygarden SJ
    Pathol Annu; 1994; 29 Pt 1():303-20. PubMed ID: 7510385
    [No Abstract]   [Full Text] [Related]  

  • 19. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
    Helpap B; Köllermann J; Oehler U
    J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in prostate cancer: prostate specific antigen (PSA) and DNA cytophotometry.
    Krause FS; Feil G; Bichler KH; Schrott KM; Akcetin ZY; Engehausen DG
    Anticancer Res; 2005; 25(3A):1783-5. PubMed ID: 16033100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.